Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence

Albeit tyrosine kinase inhibitors anti-Abl used in Chronic Myeloid Leukemia (CML) block the deregulated activity of the Bcr-Abl tyrosine kinase and induce remission in 90% of patients, they do not eradicate immature hematopoietic compartments of leukemic stem cells. To elucidate if autophagy is impo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ianniciello, Angela, Dumas, Pierre-Yves, Drullion, Claire, Guitart, Amélie, Villacreces, Arnaud, Peytour, Yan, Chevaleyre, Jean, Brunet de la Grange, Philippe, Vigon, Isabelle, Desplat, Vanessa, Priault, Muriel, Sbarba, Persio Dello, Ivanovic, Zoran, Mahon, François-Xavier, Pasquet, Jean-Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722539/
https://www.ncbi.nlm.nih.gov/pubmed/29228587
http://dx.doi.org/10.18632/oncotarget.18904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722539/
https://www.ncbi.nlm.nih.gov/pubmed/29228587
http://dx.doi.org/10.18632/oncotarget.18904

Ejemplares similares